Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-13

Clinical Trial Update: Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea

View source ↗

Summary

Results from a Takeda-sponsored Special Drug Use Surveillance study evaluate alogliptin tablets in combination with a sulfonylurea for type 2 diabetes mellitus.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Surveillance | Status: COMPLETED | Results posted: 2017-04-13